{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:05:23Z","timestamp":1790820323836,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Government of Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["FPU20\/03621"],"award-info":[{"award-number":["FPU20\/03621"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.fertnstert.2025.05.154","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:08:51Z","timestamp":1747768131000},"page":"701-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Progestin prime ovarian stimulation provides comparable outcomes to GnRH antagonist in donor cycles with vitrified oocytes"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-9345","authenticated-orcid":false,"given":"Luc\u00eda","family":"Murria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Bori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Remoh\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2025.05.154_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.fertnstert.2007.05.050","article-title":"Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method","volume":"89","author":"Cobo","year":"2008","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.fertnstert.2025.05.154_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.fertnstert.2014.06.019","article-title":"Obstetric and perinatal outcome of babies born from vitrified oocytes","volume":"102","author":"Cobo","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2022.08.015","article-title":"Comparison of pregnancy outcomes of 7515 same donor oocyte cycle fresh and cryopreserved-thawed oocytes in 609 donor oocyte recipient cycles: a single institution analysis","volume":"277","author":"Gursu","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10815-023-03016-2","article-title":"Similar pregnancy outcomes from fresh and frozen donor oocytes transferred to gestational carriers: a SART database analysis isolating the effects of oocyte vitrification","volume":"41","author":"Kloos","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","article-title":"The Practice Committees of the ASRM and the SART. Mature oocyte cryopreservation: a guideline","volume":"99","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.23736\/S2724-606X.22.05176-4","article-title":"Role and effectiveness of progestins in pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and a meta-analysis","volume":"75","author":"Yildiz","year":"2023","journal-title":"Minerva Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib11","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib12","doi-asserted-by":"crossref","first-page":"103639","DOI":"10.1016\/j.rbmo.2023.103639","article-title":"Progestin-primed ovarian stimulation: for whom, when and how?","volume":"48","author":"Ata","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial","volume":"116","author":"Giles","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.rbmo.2022.02.003","article-title":"Progesterone-primed ovarian stimulation in oocyte donation: a model for elective fertility preservation?","volume":"44","author":"Devesa","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib15","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/humrep\/deq146","article-title":"Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial","volume":"25","author":"Cobo","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1472-6483(10)60837-1","article-title":"Highly efficient vitrification method for cryopreservation of human oocytes","volume":"11","author":"Kuwayama","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10815-015-0633-9","article-title":"A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human oocytes: a retrospective cohort study","volume":"33","author":"Coello","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib18","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.fertnstert.2009.10.042","article-title":"Storage of human oocytes in the vapor phase of nitrogen","volume":"94","author":"Cobo","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.fertnstert.2024.10.006","article-title":"External validation of a fully automated evaluation tool: a retrospective analysis of 68,471 scored embryos","volume":"123","author":"Bori","year":"2025","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib20","doi-asserted-by":"crossref","first-page":"103732","DOI":"10.1016\/j.rbmo.2023.103732","article-title":"Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study","volume":"48","author":"Hendrickx","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jfma.2023.12.008","article-title":"Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: a propensity score-weighted analysis","volume":"123","author":"Duc","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/09513590.2019.1604661","article-title":"Desogestrel versus antagonist injections for LH suppression in oocyte donation cycles: a crossover study","volume":"35","author":"Mart\u00ednez","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.fertnstert.2019.06.009","article-title":"Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology","volume":"112","author":"Yildiz","year":"2019","journal-title":"Fertil Steril"},{"issue":"Supplement_1","key":"10.1016\/j.fertnstert.2025.05.154_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dead093.988","article-title":"P-662 embryo ploidy rates following PPOS or GnRH antagonist protocol. A prospective study with repeated ovarian stimulation","volume":"38","author":"Vidal Segui","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejogrb.2023.12.035","article-title":"Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: a matched case-control study in PGT-A cycles","volume":"294","author":"Vaiarelli","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2217263","article-title":"Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function","volume":"39","author":"Xu","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib27","article-title":"The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF\/ICSI: a systematic review and meta-analysis","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/life10060090","article-title":"Validating the use of corifollitropin alfa in progestin-primed ovarian stimulation protocol on normal and high responders by comparing with conventional antagonist protocol: a retrospective study","volume":"10","author":"Huang","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.fertnstert.2024.01.027","article-title":"A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response","volume":"121","author":"Chen","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib30","doi-asserted-by":"crossref","first-page":"801026","DOI":"10.3389\/fendo.2021.801026","article-title":"Progestin-primed ovarian stimulation versus mild stimulation protocol in advanced age women with diminished ovarian reserve undergoing their first In vitro fertilization cycle: a Retrospective Cohort Study","volume":"12","author":"Tu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Supplement_1","key":"10.1016\/j.fertnstert.2025.05.154_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dead093.968","article-title":"P-640 No impact of progestin primed ovarian stimulation (PPOS) on euploid blastocyst rate per cohort of metaphase-II oocytes during PGT-A cycles: a case-control study","volume":"38","author":"Rania","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib32","doi-asserted-by":"crossref","first-page":"103222","DOI":"10.1016\/j.rbmo.2023.04.013","article-title":"Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy","volume":"47","author":"Giles","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00404-020-05939-y","article-title":"Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis","volume":"303","author":"Cui","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib34","doi-asserted-by":"crossref","first-page":"702558","DOI":"10.3389\/fendo.2021.702558","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials","volume":"12","author":"Guan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib35","doi-asserted-by":"crossref","first-page":"10569","DOI":"10.1038\/s41598-024-60901-1","article-title":"Segmentation of mature human oocytes provides interpretable and improved blastocyst outcome predictions by a machine learning model","volume":"14","author":"Fjeldstad","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib36","doi-asserted-by":"crossref","first-page":"103842","DOI":"10.1016\/j.rbmo.2024.103842","article-title":"An artificial intelligence tool predicts blastocyst development from static images of fresh mature oocytes","volume":"48","author":"Fjeldstad","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib37","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.fertnstert.2023.08.233","article-title":"Higher metaphase II (MII) oocyte quality identified by an artificial intelligence (AI) oocyte image analysis tool in GnRH antagonist versus GnRH agonist controlled ovarian stimulation (COS) protocols","volume":"120","author":"Fjeldstad","year":"2023","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.fertnstert.2025.05.154_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11596-018-1908-z","article-title":"Effect of progestin-primed ovarian stimulation protocol on outcomes of aged infertile women who failed to get pregnant in the first IVF\/ ICSI cycle: a Self-controlled Study","volume":"38","author":"Chen","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.fertnstert.2022.06.012","article-title":"Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score\u2013matched study","volume":"118","author":"Chen","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib40","doi-asserted-by":"crossref","first-page":"102049","DOI":"10.1016\/j.jogoh.2020.102049","article-title":"A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders","volume":"50","author":"Cai","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/clinem\/dgad397","article-title":"Comparison of cumulative live birth rates between progestin and GnRH analogues in preimplantation genetic testing cycles","volume":"109","author":"Zhou","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib42","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.fertnstert.2020.09.157","article-title":"Artificial intelligence in human in vitro fertilization and embryology","volume":"114","author":"Zaninovic","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","article-title":"Progestin primed ovarian stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF","volume":"21","author":"Pai","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib44","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","article-title":"Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation","volume":"35","author":"La Marca","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40001-023-01000-1","article-title":"Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist\/antagonist protocol","volume":"28","author":"Wang","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.rbmo.2022.03.003","article-title":"Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol","volume":"45","author":"Yang","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00404-024-07918-z","article-title":"Progestin-primed ovarian stimulation (PPOS) in preimplantation genetic testing for aneuploidy: a retrospective study and meta-analysis","volume":"311","author":"Qin","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib48","doi-asserted-by":"crossref","first-page":"965863","DOI":"10.3389\/fendo.2022.965863","article-title":"Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib49","doi-asserted-by":"crossref","first-page":"1156620","DOI":"10.3389\/fendo.2023.1156620","article-title":"Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score\u2013matched cohort study","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2025.05.154_bib50","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10815-020-01755-0","article-title":"Impact of progestin ovarian stimulation on newborn outcomes: a meta-analysis","volume":"37","author":"Zolfaroli","year":"2020","journal-title":"J Assist Reprod Genet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502822500442X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502822500442X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:50:06Z","timestamp":1790819406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502822500442X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S001502822500442X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.05.154","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestin prime ovarian stimulation provides comparable outcomes to GnRH antagonist in donor cycles with vitrified oocytes","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.05.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}